
AI has the potential to transform healthcare delivery yet there is an urgent need for governance processes to guide the safe, fair, and secure adoption of AI in clinical settings. Stanford HAI’s multidisciplinary Healthcare AI Policy Steering Committee conducts research and convenes discussions to develop tangible recommendations for policymakers.
Stanford HAI’s Healthcare AI Policy Steering Committee is a multidisciplinary committee of Stanford faculty and scholars that are working together to advance the governance of healthcare AI. The group brings together academics, physicians, lawyers, computer scientists, and ethicists who believe deeply in both the power of AI applications to transform healthcare delivery and the urgent need to review existing regulatory frameworks to ensure these tools are safe, fair, and secure for clinical use.
By conducting interdisciplinary, evidence-based research and convening multi-stakeholder discussions, the committee aims to develop tangible recommendations for policymakers that help ensure healthcare AI can benefit patients, doctors, and developers alike.
Every year — as part of Stanford’s Health AI Week — the committee convenes a closed-door policy workshop to discuss policy challenges with a select group of leading policymakers, scientists, healthcare providers, ethicists, AI developers, and patient advocates.
In May 2024, participants discussed gaps in federal policy related to AI software for clinical decision support, healthcare enterprise AI tools, and patient-facing AI.
In June 2025, the focus was on patient perspectives as participants explored policy challenges in AI-related payment policy, insurance decisions, and patient trust.
In June 2026, the discussion focused on emerging efforts to regulate the use of AI in mental health, for therapy and emotional support.
Our committee members publish timely research at the intersection of healthcare, law, policy, ethics, and AI. We highlight a selection of their latest research papers at the bottom of this page.













Get the latest news, advances in research, policy work, and education program updates from HAI in your inbox weekly.
Sign Up For Latest News



Stanford scholars respond to a federal request for feedback, offering policy recommendations for the regulation of generative AI-enabled medical devices.

This brief demonstrates how real-time monitoring can address critical gaps in the oversight of radiological AI tools.

This brief proposes governance mechanisms for the growing use of AI in health insurance utilization review.

Stanford scholars respond to a federal RFC on evaluating AI-enabled medical devices, recommending policy interventions to help mitigate the harms of AI-powered chatbots used as therapists.

In this testimony presented to the U.S. Senate Committee on Health, Education, Labor, and Pensions hearing titled “AI’s Potential to Support Patients, Workers, Children, and Families,” Russ Altman highlights opportunities for congressional support to make AI applications for patient care and drug discovery stronger, safer, and human-centered.
Recent polls show that healthcare costs are a top affordability concern for American adults and that a large majority of adults, 90% of Democrats and 75% of Republicans, support a fundamental redesign or major changes to our healthcare system. Across states, political parties, and different types of office, politicians and constituents hold different views on healthcare policies and support different proposals. Various stakeholders such as patients, physicians, nurses, veterans, employers, and industry groups could potentially benefit from access to data on how their representatives’ views align with their own. There is no systematic, openly available database and analysis of these views. We sought to create the first systematic, openly available database and analysis of the healthcare policies and proposals of the leading candidates in the November 2026 elections and beyond.
Recent polls show that healthcare costs are a top affordability concern for American adults and that a large majority of adults, 90% of Democrats and 75% of Republicans, support a fundamental redesign or major changes to our healthcare system. Across states, political parties, and different types of office, politicians and constituents hold different views on healthcare policies and support different proposals. Various stakeholders such as patients, physicians, nurses, veterans, employers, and industry groups could potentially benefit from access to data on how their representatives’ views align with their own. There is no systematic, openly available database and analysis of these views. We sought to create the first systematic, openly available database and analysis of the healthcare policies and proposals of the leading candidates in the November 2026 elections and beyond.
By January 2027, 44 state Medicaid programs must redetermine the eligibility of millions of beneficiaries under criteria in the 2025 budget reconciliation law (HR 1). Among the changes are “community engagement” (work) requirements and increased redetermination cadence (from annual to at least semiannual). In preparation, state Medicaid agencies have been exploring technological solutions to automate redeterminations at scale, including artificial intelligence (AI). Six agencies have decided to use AI tools so far and 21 states are considering use of them. Strategic deployment of AI can help states tackle the redetermination juggernaut, but overly broad or hasty deployment could compound the harms of HR 1.
By January 2027, 44 state Medicaid programs must redetermine the eligibility of millions of beneficiaries under criteria in the 2025 budget reconciliation law (HR 1). Among the changes are “community engagement” (work) requirements and increased redetermination cadence (from annual to at least semiannual). In preparation, state Medicaid agencies have been exploring technological solutions to automate redeterminations at scale, including artificial intelligence (AI). Six agencies have decided to use AI tools so far and 21 states are considering use of them. Strategic deployment of AI can help states tackle the redetermination juggernaut, but overly broad or hasty deployment could compound the harms of HR 1.
The US spends 25 percent of all health care costs on administration, a big part of which involves billing for medical services. To realize savings requires standardizing and digitizing billing.
The US spends 25 percent of all health care costs on administration, a big part of which involves billing for medical services. To realize savings requires standardizing and digitizing billing.
In January 2026, Utah announced a first-of-its kind pilot program allowing an autonomous artificial intelligence (AI) agent to renew prescriptions for consumers who request it. The state agreed not to enforce its unprofessional conduct laws against the developer, Doctronic, if the company adheres to a contract that includes safety and privacy protections. The pilot program includes 192 drugs for chronic conditions. Although physicians will initially validate the AI’s actions, the pilot program will swiftly become one of the first deployments at scale of an autonomous, agentic system in medicine. The announcement prompted concern from associations of physicians and pharmacists who opined that AI “should NOT be making care decisions.”
In January 2026, Utah announced a first-of-its kind pilot program allowing an autonomous artificial intelligence (AI) agent to renew prescriptions for consumers who request it. The state agreed not to enforce its unprofessional conduct laws against the developer, Doctronic, if the company adheres to a contract that includes safety and privacy protections. The pilot program includes 192 drugs for chronic conditions. Although physicians will initially validate the AI’s actions, the pilot program will swiftly become one of the first deployments at scale of an autonomous, agentic system in medicine. The announcement prompted concern from associations of physicians and pharmacists who opined that AI “should NOT be making care decisions.”
Health insurers and health care provider organizations are increasingly using artificial intelligence (AI) tools in prior authorization and claims processes. AI offers many potential benefits, but its adoption has raised concerns about the role of the “humans in the loop,” users’ understanding of AI, opacity of algorithmic determinations, underperformance in certain tasks, automation bias, and unintended social consequences. To date, institutional governance by insurers and providers has not fully met the challenge of ensuring responsible use. However, several steps could be taken to help realize the benefits of AI use while minimizing risks. Drawing on empirical work on AI use and our own ethical assessments of provider-facing tools as part of the AI governance process at Stanford Health Care, we examine why utilization review has attracted so much AI innovation and why it is challenging to ensure responsible use of AI. We conclude with several steps that could be taken to help realize the benefits of AI use while minimizing risks.
Health insurers and health care provider organizations are increasingly using artificial intelligence (AI) tools in prior authorization and claims processes. AI offers many potential benefits, but its adoption has raised concerns about the role of the “humans in the loop,” users’ understanding of AI, opacity of algorithmic determinations, underperformance in certain tasks, automation bias, and unintended social consequences. To date, institutional governance by insurers and providers has not fully met the challenge of ensuring responsible use. However, several steps could be taken to help realize the benefits of AI use while minimizing risks. Drawing on empirical work on AI use and our own ethical assessments of provider-facing tools as part of the AI governance process at Stanford Health Care, we examine why utilization review has attracted so much AI innovation and why it is challenging to ensure responsible use of AI. We conclude with several steps that could be taken to help realize the benefits of AI use while minimizing risks.

Policymakers, academics, healthcare providers, AI developers, and patient advocates convened by Stanford HAI identify critical gaps in how we regulate AI tools used for therapy and emotional support.